110 days ago
With just three patients in phase 1 trials Hemogenyx (HEMO) is at an incredibly early stage of drug development. But at least it is doing something, until recently it has just been a lifestyle business for its cock of a CEO Vlad Sandler. Today a prospectus is out, allowing yet more confetti to start trading. Turn to page 7
166 days ago
With a hap tip to readers T and K the details of the US phase 1 trial of Hemogenyx’s (HEMO) AML drug can now be revealed and it is not good news for deluded fools like Christopher Kilner who own the shares. Oh no…
172 days ago
I was promised an imminent update of the health status of patients 1 and 2 by an advisor to overpromoted box of snakes shitco Hemogenyx (HEMO) two days ago. I have heard nothing which makes me fear for their health. They will be in my prayers tonight since had they been running half marathons I would have had a speedy response saying just that. And this silence, as I explained HERE, should make shareholders run for the hills.
174 days ago
Forgive my reminiscing back to, I think, 1995 or maybe 1996 but this is pertinent as I consider the valuaton of Hemogenyx (HEMO) and what Vlad Sandler is NOT telling us about his phase 1 trials.
195 days ago
Shares in the worthless lifestyle company Hemogenyx (HEMO) have raced ahead by 68% today to 316p after a placing raising gross proceeds of £570,000 at 180p was announced yesterday. Lets call it £520,000 net and that tells you that ghastly boss Vald Sandler will be passing the hat around yet again before Christmas.
302 days ago
It was running on vapours so it’s no shock that Hemogenyx (HEMO), the pointless main market listed lifestyle company run by pompous prick Vlad Sandler has placed yet again, raising £451,000 gross at 180.5p. That will keep the wolf from the door for a couple of months by when Vlad will have to do another funding. But this one stinks, the RNS looks like its a lie.
340 days ago
358 days ago
364 days ago
377 days ago